Renflexis (infliximab-abda) / Yuhan Corp, Biogen, Samsung, Organon, Ewopharma 
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Renflexis (infliximab-abda) / Yuhan Corp, Biogen, Ewopharma, Samsung, Organon
2018-001546-33: The effects of switching one drug, used to treat either Ulcerative Colitis (UC) or Crohn’s disease (CD) to another drug, also used to treat UC or Crohn’s disease

Not yet recruiting
4
200
Europe
Flixabi, Infusion, Flixabi
University Southampton Hospital NHS Foundation Trust, Biogen Idec Ltd
Inflammatory Bowel Disease in particular Crohn's Disease and Ulcerative Colitis, Crohn’s Disease: Inflammation of the digestive system or gutUlcerative Colitis: Inflammation and ulceration of the large bowel, Diseases [C] - Digestive System Diseases [C06]
 
 
FREE, NCT04646187 / 2020-001811-26: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Enrolling by invitation
4
148
Europe
Infliximab, Remicade, Flixabi, Inflectra, Remsima, Zessly, Adalimumab, Humira, AMGEVITA, Hulio, Hyrimoz, Idacio, Imraldi
University Medical Center Groningen, European Crohn´s and Colitis Organisation, Bühlmann Laboratories AG
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
03/25
03/25
REMODEL-CD, NCT05660746: Precise Infliximab Exposure and Pharmacodynamic Control

Recruiting
2/3
180
US
RoadMAB, Infliximab, Avsola, Inflectra, Ixifi, Remicade, Renflexis
Children's Hospital Medical Center, Cincinnati, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Janssen Scientific Affairs, LLC
Crohn Disease
03/27
03/27

Download Options